Skip to content

Look Up Your Peptide See Its Grade on Human Trials.

We grade 57 compounds A to D on completed randomized human trials. We print no doses, and no seller pays for a place.

The Fake GLP-1 Check

Is the pen in your fridge real?

Seven signs of a fake Ozempic or Mounjaro pen, from the FDA's three alerts. Free.

Read the first three checks

Instant download. The Wednesday email comes with it, plus one alert when a lot number is added or a seller is charged. Unsubscribe anytime. Privacy

BPC-157 has no completed randomized human trial. Neither do eight others on this Table.

Each tile is one compound. The letter is its grade for human evidence. The number is its count of completed randomized trials. How we count a trial.

Grade DNo randomized trial9

No completed randomized human trial. Case reports or uncontrolled studies at most.

Grade CSmall studies11

Randomized studies that only measured the body's response.

Grade BSome trials10

At least one completed randomized trial of a health outcome.

Grade ALarge trials27

Several completed randomized trials of a health outcome, at the scale that supports an approval.

The questions people ask before they buy.

The FAQ

What does 'research use only' actually mean?

'Research use only' means a product is labelled for lab research and not for people. It is a labelling category, and no regulator has assessed the material for human use. US and EU law judge a product by its intended use, so the label does not change what a product legally is, and it guarantees nothing about purity.

Read the full answer

21 sources · 6 min read

How can you tell if a peptide vendor is legitimate?

Legitimacy signals include a bulk substance made at an FDA-registered establishment, a valid certificate of analysis, and, in the EU, a manufacturer listed in EudraGMDP. None of this is verified by the seller's own label. Research use only labelling has no bearing on legitimacy and does not exempt a seller from enforcement.

Read the full answer

11 sources · 4 min read

Is BPC-157 safe?

BPC-157 has not completed a human safety trial. FDA's May 2026 safety review identified only five small human studies, with no reported serious adverse events but also no adequate safety monitoring or chronic-use data. FDA staff concluded in May 2026 that the evidence weighs against placing it on the compounding list. HHS has since said it does not intend to take enforcement action against licensed compounders who meet its conditions. That is not a safety finding. The honest answer is unknown, not safe or dangerous.

Read the full answer

11 sources · 5 min read

How do you read a certificate of analysis?

A certificate of analysis typically reports HPLC purity, mass-spectrometry identity, and sometimes endotoxin testing, three separate measurements. None of these results mean anything without a validated method behind them, covering accuracy, precision and specificity. A certificate that omits method, reference standard, or contamination data is reporting less than a full quality picture.

Read the full answer

8 sources · 5 min read

Is compounded semaglutide the same as Ozempic?

No. Compounded semaglutide is not the same as Ozempic. Ozempic is one approved product made by Novo Nordisk [1, 8]. The main difference in compounded semaglutide vs Ozempic is review: the FDA does not check compounded drugs for safety, effectiveness or quality before they are sold [5]. As of October 2026, the shortage exception that allowed wide compounding has been closed since 2025 [2].

Read the full answer

10 sources · 4 min read